JP2005507381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507381A5 JP2005507381A5 JP2003523181A JP2003523181A JP2005507381A5 JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5 JP 2003523181 A JP2003523181 A JP 2003523181A JP 2003523181 A JP2003523181 A JP 2003523181A JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- dibromo
- isopropyl
- hydroxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0120691A GB0120691D0 (en) | 2001-08-24 | 2001-08-24 | Novel Compounds |
| GB0207719A GB0207719D0 (en) | 2002-04-03 | 2002-04-03 | Novel compounds |
| PCT/EP2002/009120 WO2003018515A2 (en) | 2001-08-24 | 2002-08-13 | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005507381A JP2005507381A (ja) | 2005-03-17 |
| JP2005507381A5 true JP2005507381A5 (https=) | 2006-06-22 |
Family
ID=26246475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003523181A Pending JP2005507381A (ja) | 2001-08-24 | 2002-08-13 | 心臓障害および代謝障害の治療のための主要環置換甲状腺受容体アンタゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7279593B2 (https=) |
| EP (1) | EP1499578A2 (https=) |
| JP (1) | JP2005507381A (https=) |
| KR (1) | KR20040027927A (https=) |
| AU (1) | AU2002331145B2 (https=) |
| CA (1) | CA2449515A1 (https=) |
| IL (1) | IL159006A0 (https=) |
| WO (1) | WO2003018515A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1435946B8 (en) * | 2001-09-14 | 2013-12-18 | Amgen Inc. | Linked biaryl compounds |
| WO2006128058A2 (en) | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
| CN1882327A (zh) | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| GB0406380D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
| TWI534144B (zh) | 2009-04-20 | 2016-05-21 | 田邊三菱製藥股份有限公司 | 甲狀腺荷爾蒙β受體作動藥 |
| CA3044059A1 (en) | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| US11707472B2 (en) | 2017-06-05 | 2023-07-25 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| CA3075877A1 (en) | 2017-09-14 | 2019-03-21 | Riken | Method for producing retinal tissues |
| ES3053674T3 (en) | 2018-03-22 | 2026-01-23 | Viking Therapeutics Inc | Crystalline forms and methods of producing crystalline forms of a compound |
| WO2020117962A1 (en) | 2018-12-05 | 2020-06-11 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis and inflammation |
| KR20210138639A (ko) | 2019-03-13 | 2021-11-19 | 다이니뽄 스미토모 세이야쿠 가부시키가이샤 | 이식용 신경 망막의 품질을 평가하는 방법 및 이식용 신경 망막 시트 |
| EP4201428A4 (en) | 2020-09-11 | 2024-09-11 | Sumitomo Pharma Co., Ltd. | MEDIUM FOR TISSUE INTENDED FOR TRANSPLANTATION |
| CA3194226A1 (en) | 2020-09-11 | 2022-03-17 | Riken | Complex containing neural retina-containing cell aggregates and matrix, and method for manufacturing same |
| WO2023090427A1 (ja) | 2021-11-19 | 2023-05-25 | 国立研究開発法人理化学研究所 | シート状網膜組織の製造方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8501372D0 (en) | 1985-01-18 | 1985-02-20 | Smith Kline French Lab | Chemical compounds |
| EP0580550B1 (en) * | 1992-07-21 | 1997-10-22 | Novartis AG | Oxamic acid derivatives as hypocholesteremic agents |
| EP0831769B2 (en) | 1995-06-07 | 2008-07-23 | Lavin, Dr., Thomas N. | Novel uses for thyroid hormones or thyroid hormone-like compounds |
| GB9713739D0 (en) * | 1997-06-27 | 1997-09-03 | Karobio Ab | Thyroid receptor ligands |
| GB9816935D0 (en) * | 1998-08-05 | 1998-09-30 | Karobio Ab | Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders |
| GB9828442D0 (en) | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| GB9927056D0 (en) * | 1999-11-17 | 2000-01-12 | Karobio Ab | Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| WO2001072692A1 (en) * | 2000-03-31 | 2001-10-04 | Pfizer Products Inc. | Malonamic acids and derivatives thereof as thyroid receptor ligands |
| WO2001085670A1 (en) | 2000-05-12 | 2001-11-15 | Kissei Pharmaceutical Co., Ltd. | Malonanilic acid derivatives, medicinal compositions containing the same and use thereof |
-
2002
- 2002-08-13 EP EP02767384A patent/EP1499578A2/en not_active Withdrawn
- 2002-08-13 JP JP2003523181A patent/JP2005507381A/ja active Pending
- 2002-08-13 AU AU2002331145A patent/AU2002331145B2/en not_active Ceased
- 2002-08-13 KR KR10-2004-7002447A patent/KR20040027927A/ko not_active Ceased
- 2002-08-13 CA CA002449515A patent/CA2449515A1/en not_active Abandoned
- 2002-08-13 IL IL15900602A patent/IL159006A0/xx unknown
- 2002-08-13 WO PCT/EP2002/009120 patent/WO2003018515A2/en not_active Ceased
- 2002-08-13 US US10/485,849 patent/US7279593B2/en not_active Expired - Fee Related